Paul Smith

Articles by Paul Smith

FDA approves low-dose pilocarpine hydrochloride 0.4% as a treatment for presbyopia

ByLynda Charters,Emily Kaiser Maharjan, Assistant Managing Editor,Elad Kedar,Paul Smith

October 18th 2023

Qlosi (Orasis Pharmaceuticals) approved to treat presbyopia.

SECO 2023: Orasis Pharmaceuticals presents pipeline update at OIS

ByPaul Smith,Emily Kaiser Maharjan, Assistant Managing Editor,Kassi Filkins, Editor

March 3rd 2023

Paul Smith shares an update on Orasis Pharmaceutical's CSF-1 drug and what to expect this year.

Latest Updated Articles

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

WaveDȳn integrates with Bausch + Lomb and WAVE for scleral lens fitting

Remote Area Medical: Lindsay Elkins, OD, FAAO, on care for underserved communities

Study finds that current ophthalmic patient letters may pose comprehension difficulty

Artelo Biosciences enrolls first patient in phase 2 DREAM study in patients with glaucoma